| |
|
|
|
Avadel Pharmaceuticals plc  
|
|
1.15 -0.02 (-0.02%) |
04-18 16:00 |
|
Open: |
1.18 |
Pre close: |
1.17 |
Target:
|
2.01
|
|
High: |
1.19 |
Low: |
1.1165 |
Resistance:
|
1.72
2.10
|
|
Volume: |
126,437 |
Market Cap: |
43M |
Support:
|
1.11
0.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.21
 |
MACD |
MACD(12,26):
|
-0.16 |
|
MA(20): |
1.36 |
Signal(12,26,9): |
-0.17  |
|
MA(100): |
2.21 |
Stochastic Oscillator |
%K(14,3):
|
15.30 |
|
MA(250): |
4.20 |
%D(3): |
17.82 |
|
Average Volume(K) |
3-Month: |
15029
|
52-Week |
High:
|
7.97 |
|
10-Days: |
20781 |
Low: |
1.11 |
|
RSI |
RSI(14):
|
29.60 |
Change(%): |
-83.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.000 |
Return on Equity (ttm) |
-215.7 |
Shares Out. (M) |
37.01 |
|
EPS Est. Current Year |
1.160 |
Return on Assets (ttm) |
-43.0 |
Shares Float (M) |
35.72 |
|
EPS Est. Next Year |
0.250 |
PEG Ratio |
0.12 |
% Held by Insiders |
3.50 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-39.8 |
% Held by Institutions |
64.70 |
|
Forward EPS |
-0.060 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
17.870 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.57 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.06 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-82.72 |
P/S |
15510468.00 |
|
Operating Margin |
-58.64 |
Levered Free Cash Flow
(M) |
-84.39 |
P/CF |
-0.51 |
|
|
|
|
|
|
